Can I thank the Cabinet Secretary for his reply and thank him also for the decision that he has taken in the last few days, and thank him for the time that he and his officials have made available to myself and others to discuss this important matter?

The health, emotional relationship and social consequences of an HIV diagnosis can be very, very serious, and although many, many people are living into later life with HIV medication, it’s incumbent on us to make available to people in Wales the tools that they need to manage their health prudently and to reduce HIV transmission. The clinical effectiveness of Truvada is well established—between 86 and 100 per cent effective at reducing HIV transmission as part of a range of safe sex measures. So, I welcome the decision that he has taken.

He has mentioned that this will be rolled out across Wales. Can he confirm that it will be available across Wales from the outset, mindful of the fact that there is an uneven distribution, if you like, of genitourinary medicine clinics across Wales? Secondly, from the perspective of the patient, will participating in the study alter that experience for the patient? Will there be additional expectations from the patient, above and beyond the clinical expectations? Thirdly, what measures does he envisage being taken to raise awareness amongst communities that are particularly at risk of HIV transmission of the availability of PrEP on the NHS in Wales?